Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Gleevec
Descriptions
Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called an antineoplastic (cancer) agent. Imatinib is used for these conditions:
-
Aggressive systemic mastocytosis (ASM)
-
Chronic eosinophilic leukemia (CEL)
-
Dermatofibrosarcoma protuberans (DFSP)
-
Gastrointestinal stromal tumors (GIST)
-
Hypereosinophilic syndrome (HES)
-
Myelodysplastic syndrome (MDS)
-
Myeloproliferative diseases (MPD)
-
Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)
-
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML)
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: July 01, 2021
Copyright © 2021 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.